TRESOROL 200/62.5/25MCG CAP

TRESOROL is a combination inhalation capsule containing fluticasone furoate, umeclidinium, and vilanterol. This triple-action formulation is designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. Fluticasone furoate works as an inhaled corticosteroid to reduce airway inflammation, while umeclidinium is a long-acting muscarinic antagonist that helps relax airway muscles. Vilanterol, a long-acting beta-2 agonist, provides bronchodilation support. Each capsule delivers 200mcg fluticasone furoate, 62.5mcg umeclidinium, and 25mcg vilanterol for consistent daily dosing. Suitable for patients requiring comprehensive COPD management with a single convenient medication. Always use as directed by your healthcare provider. Store in a cool, dry place away from moisture.